SCHEMBL6835810

SCHEMBL6835810

N#Cc1ccc(NC(=O)c2noc3ccc(NC(=O)C4CCC4)cc23)c(C(=O)O)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALB P02768 2/20 0.39
HIF1A Q16665 5/20 0.38
IP6K1 Q92551 1/20 0.37
IP6K3 Q96PC2 1/20 0.37
IP6K2 Q9UHH9 1/20 0.37
KDM4E B2RXH2 3/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
HSD17B10 Q99714 2/20 0.37
ALDH1A1 P00352 1/20 0.37
GAA P10253 1/20 0.37
TP53 P04637 1/20 0.36
PDE10A Q9Y233 1/20 0.36
MAPT P10636 1/20 0.36
USP2 O75604 1/20 0.36
POLB P06746 1/20 0.36
HPGD P15428 1/20 0.36
TSHR P16473 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
GRM4 Q14833 1/20 0.35
GBA1 P04062 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6819320 0.86 IP6K1 (0.45) ALBIP6K1IP6K3IP6K2KDM4E
SCHEMBL6835869 0.85 HIF1A (0.41) ALBHIF1A
SCHEMBL6833068 0.84 ALB (0.39) ALBHIF1APDE10ACETP
SCHEMBL6834155 0.84 F2 (0.50) ALBHIF1AMAPT
SCHEMBL6713135 0.83 HIF1A (0.36) HIF1AKDM4ESMN1; SMN2HSD17B10ALDH1A1
SCHEMBL6711846 0.82 ULK1 (0.35) HIF1AKDM4ESMN1; SMN2ALDH1A1GAA
SCHEMBL6833108 0.82 HIF1A (0.39) ALBHIF1APDE10ACETP
SCHEMBL6834064 0.81 ALB (0.42) ALBHIF1ATP53MAPTPOLB
SCHEMBL6833569 0.81 CDK2 (0.40) ALBHIF1A
SCHEMBL6833806 0.81 KDM4C (0.45) ALBHIF1ACETP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040110802-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110802-A1 Antibacterial benzoic acid derivatives GABRD, GABBR1, GABRA1 ALB 1417/4885HIF1A 220/4885IP6K1 4307/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.